loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 211617 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ESPERION THERAPS INC (1)

filter

01 TABLET;ORAL (1)

filter

01 RX (1)

filter

01 NEXLIZET (1)

filter

01 Yes (1)

URL Supplier Web Content
TABLET; ORAL
180MG;10MG
2020-02-26
211617
NEXLIZET
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 211617

Looking for FDA Orange Book APPLICATION 211617 1

19

Esperion Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is BEMPEDOIC ACID; EZETIMIBE, with a corresponding application number 211617.

Regulatory Information RX

With a dosage strength 180MG;10MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2020-02-26

Post Enquiry
POST ENQUIRY